Dr Ian Morgan , Prof David Mackey , Prof Seang Mai Saw, Dr Antony Clark, Prof Giovanni Staurenghi, Ramin Salouti, MD
Synopsis: An epidemic of myopia is underway. Up to 90% of Asian schoolchildren have myopia and 20% of these have high myopia. An epidemic of high myopia is also anticipated. There has been recent progress in understanding of environmental factors and genetics of myopia; treat- ment trials to retard myopia progression are underway. New imaging modalities have increased our understanding of the myopic maculopathies. Progress has been made in surgical treatment of myopic maculopathies and peripheral retinal pathologies. Anterior segment surgery is helpful for those patients who wish to be spectacle free, with options including refractive corneal laser, clear lens extraction with intraocular lens implantation, and implanted intraocular lenses, each of which has risks, beneﬁts and speciﬁc indications.
Objectives: To gain a better understanding of the following:
Epidemiology of myopia and high myopia Genetics of myopia
Environmental inﬂuences on myopia Trials of atropine to retard myopia Classiﬁcation of myopic maculopathies
Role of vitreo-surgery in treating myopic macular complications Role of anterior segment approaches for correction of myopia.
IRREVERSIBLE LENALIDOMIDE RELATED OPTIC NEUROPATHY IN A PATIENT WITH CHRONIC MYELOID LEUKAEMIA
A cost-effectiveness analysis of AcrySof IQ vivity intraocular lens from private health fund perspective in Australia
Efficacy and safety of intravitreal pegcetacoplan in geographic atrophy: Results from the phase 3 DERBY and OAKS trials